Discover 1,776 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,776
Active & Responsive
Transcranial Magnetic Brain Stimulation to Reduce Cannabis Use in Heavy Cannabis Users
for
Cannabis
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18 - 65
Code: NCT05401929
Recruiting
Active & Responsive
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Durham NC, Columbia SC, Charlottesville VA,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05338697
Recruiting
Active & Responsive
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
for
Adrenoleukodystrophy, Batten Disease, Mucopolysaccharidosis II,
Location: Durham NC
Sponsor: Joanne Kurtzberg, MD
Sex: All
Age: 0 - 22
Code: NCT02254863
Phase 1, Recruiting
Active & Responsive
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
for
High-Risk Neuroblastoma
Location: Durham NC, Philadelphia PA, The Bronx NY, Toronto,
Sponsor: Renaissance Pharma Ltd.
Sex: All
Age: 1 - 18
Code: NCT07549321
Phase 2, Phase 3, Recruiting
Active & Responsive
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
for
Immune Thrombocytopenic Purpura (ITP)
Location: Durham NC, Greenville NC, Norfolk VA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06722235
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
for
Liver Transplant
Location: Durham NC, Baltimore MD, Pittsburgh PA, Philadelphia PA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18+
Code: NCT06075745
Phase 2, Recruiting
Active & Responsive
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Location: Durham NC, Fairfax VA, Washington D.C. DC, Nashville TN,
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 18+
Code: NCT05786924
Phase 1, Phase 2, Recruiting
Active & Responsive
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: Durham NC, Charlotte NC, Richmond VA, Lexington KY,
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05722418
Phase 1, Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Durham NC, Charlottesville VA, Richmond VA,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase 2, Phase 3, Recruiting
Active & Responsive
HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM
for
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06822972
Phase 2, Recruiting
Active & Responsive
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
for
Hematologic Malignancy
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06731504
Early Phase 1, Recruiting
Active & Responsive
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
for
Cytomegalovirus Prophylaxis
Location: Durham NC, Charlotte NC, Atlanta GA, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT07199465
Phase 1, Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Durham NC, Cary NC, Raleigh NC, Blacksburg VA,
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for
Parkinson Disease
Location: Durham NC, Asheville NC, Augusta GA, Lexington KY,
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All
Age: 30 - 70+
Code: NCT07432958
Phase 2, Recruiting
Active & Responsive
Opioids, Low Nicotine Cigarettes, and Chronic Pain